Cargando…
BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer
BACKGROUND: Lack of reliable predictive biomarkers is a stumbling block in the management of prostate cancer (CaP). Prostate-specific antigen (PSA) widely used in clinics has several caveats as a CaP biomarker. African-American CaP patients have poor prognosis than Caucasians, and notably the serum-...
Autores principales: | Siddique, Hifzur Rahman, Parray, Aijaz, Zhong, Weixiong, Karnes, R. Jeffery, Bergstralh, Eric J., Koochekpour, Shahriar, Rhim, Johng S., Konety, Badrinath R., Saleem, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538726/ https://www.ncbi.nlm.nih.gov/pubmed/23308129 http://dx.doi.org/10.1371/journal.pone.0052993 |
Ejemplares similares
-
Correction: BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer
por: Siddique, Hifzur Rahman, et al.
Publicado: (2013) -
BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling
por: Siddique, Hifzur Rahman, et al.
Publicado: (2013) -
Castration-resistant prostate cancer: potential targets and therapies
por: Parray, Aijaz, et al.
Publicado: (2012) -
Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells
por: Panigrahi, Gati K., et al.
Publicado: (2018) -
Author Correction: Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells
por: Panigrahi, Gati K., et al.
Publicado: (2018)